| Transaction Date | Recipient | Shares | Type | Price | Value |
|---|---|---|---|---|---|
| 1st March 2021 | Bart C Shuldman | 1,590 | Grant/award etc. | $0.00 | |
| 1st March 2021 | Steven A Demartino | 417 | Grant/award etc. | $0.00 | |
| 1st March 2021 | Thomas R Schwarz | 900 | Grant/award etc. | $0.00 | |
| 1st March 2021 | Bart C Shuldman | 1,199 | Grant/award etc. | $9.89 | $11,858.11 |
| 1st March 2021 | John Dillon | 900 | Grant/award etc. | $0.00 | |
| 27th February 2021 | Bart C Shuldman | 4,245 | Grant/award etc. | $0.00 | |
| 27th February 2021 | John Dillon | 1,200 | Grant/award etc. | $0.00 | |
| 27th February 2021 | Thomas R Schwarz | 1,200 | Grant/award etc. | $0.00 | |
| 27th February 2021 | Bart C Shuldman | 4,110 | Grant/award etc. | $0.00 | |
| 27th February 2021 | Thomas R Schwarz | 1,150 | Grant/award etc. | $0.00 |
Trans Act Technologies
Based on disclosure changes, sentiment, insider trading and news impact we give a rating of 7/10.
TransAct Technologies, Inc. operates as a software-driven technology and printing solutions company. It supplies consumables used in the printing and scanning activities of customers in the hospitality, banking, retail, gaming, government and oil and gas exploration markets. The company was founded in June 1996 and is headquartered in Hamden, CT.
Ticker: TACT
Sector: Electronic Technology
Industry: Computer Peripherals
SEC Central Index Key (CIK): 1017303
Employees: 134
Exchange: NASDAQ
Auditor Opinion:
You must Login to see Language Changes
Disclosure Language changes
You must Login to see analysis
Red Flags
There were no Red Flags found
Fundamentals
Cash at Carrying Value: $3 M (-26%)
Inventory, Net: $12 M (0%)
Other Assets, Current: $970 Th (-2%)
Assets, Current: $19 M (-21%)
Property, Plant and Equipment, Net: $2 M (6%)
Other Assets, Noncurrent: $218 Th (395%)
Assets: $35 M (-3%)
Accounts Payable, Current: $1 M (-55%)
Accrued Liabilities, Current: $3 M (-13%)
Liabilities, Current: $5 M (-29%)
Other Liabilities, Noncurrent: $170 Th (2%)
Liabilities: $11 M (9%)
Common Stock, Value, Issued: $116 Th (0%)
Common Stock, Shares, Issued: $12 M (0%)
Additional Paid in Capital, Common Stock: $33 M (2%)
Retained Earnings (Accumulated Deficit): $23 M (-11%)
Accumulated Other Comprehensive Income (Loss), Net of Tax: $50 Th (61%)
Treasury Stock, Value: $321 Th (0%)
Treasury Stock, Shares: $40 M (0%)
Stockholders' Equity (Parent): $24 M (0%)
Liabilities and Equity: $35 M (-3%)
Revenue: $5 M (0%)
Gross Margin: $2 M (-68%)
Research and Development: $1 M (-50%)
Sales and Marketing: $1 M (-60%)
General and Administrative Expenses: $2 M (-53%)
Operating Income/Loss: $3 M (-32%)
Other Income, net: $36 Th (-81%)
Income before taxes: $3 M (-34%)
Provision for income taxes: $921 Th (0%)
EPS (basic): $0.25 (0%)
EPS (diluted): $0.25 (0%)
